Kedrion Biopharma Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
5,200
- Latest Deal Type
-
Accelerator/Inc
- Financing Rounds
-
14
- Investments
-
7
Kedrion Biopharma General Information
Description
Manufacturer of plasma-derived products intended for the treatment of patients suffering from rare and chronic conditions. The company develops, produces and distributes human plasma-derived therapies for use in the treatment of hemophilia, immunodeficiencies and other severe debilitating conditions, enabling clients to get safer products.
Contact Information
Website
www.kedrion.comCorporate Office
- Loc. Ai Conti
- Castelvecchio Pascoli
- 55051 Barga(Lucca)
- Italy
Corporate Office
- Loc. Ai Conti
- Castelvecchio Pascoli
- 55051 Barga(Lucca)
- Italy
Kedrion Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kedrion Biopharma Comparisons
Industry
Financing
Details
Kedrion Biopharma Competitors (4)
One of Kedrion Biopharma’s 4 competitors is KEDPlasma, a Corporation company based in Mobile, AL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| KEDPlasma | Corporation | Mobile, AL | ||||
| CSL Behring | Corporation | King Of Prussia, PA | ||||
| Assertio Holdings | Formerly VC-backed | Lake Forest, IL | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD |
Kedrion Biopharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kedrion Biopharma Patents
Kedrion Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017326469-A1 | Process for plasminogen purification starting from human plasma | Inactive | 13-Sep-2016 | ||
| CA-3036425-A1 | Process for plasminogen purification starting from human plasma | Pending | 13-Sep-2016 | ||
| EP-3512940-A1 | Process for plasminogen purification starting from human plasma | Active | 13-Sep-2016 | ||
| US-11591587-B2 | Process for plasminogen purification starting from human plasma | Active | 13-Sep-2016 | ||
| US-20190330611-A1 | Process for plasminogen purification starting from human plasma | Active | 13-Sep-2016 | C12N9/6435 |
Kedrion Biopharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kedrion Biopharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kedrion Biopharma Investments (7)
Kedrion Biopharma’s most recent deal was a Buyout/LBO with UNICAplasma. The deal was made on 05-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| UNICAplasma | 05-Dec-2022 | Buyout/LBO | Clinics/Outpatient Services | ||
| Bio Products Laboratory | 01-Sep-2022 | Buyout/LBO | Biotechnology | ||
| Grifols Canada Plasma | 21-May-2021 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Entegrion | 19-Mar-2014 | Later Stage VC | Diagnostic Equipment | ||
| Ortho Clinical Diagnostics (RhoGam Business) | 31-Jul-2012 | Buyout/LBO | Clinics/Outpatient Services |
Kedrion Biopharma Exits (1)
Kedrion Biopharma’s most recent exit was on 21-May-2021 from Grifols Canada Plasma. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Grifols Canada Plasma | 21-May-2021 | Completed |
|
Kedrion Biopharma Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bio Products Laboratory | Elstree, United Kingdom | 1952 | |
| UNICAplasma | Prague, Czech Republic |
Kedrion Biopharma FAQs
-
When was Kedrion Biopharma founded?
Kedrion Biopharma was founded in 2001.
-
Where is Kedrion Biopharma headquartered?
Kedrion Biopharma is headquartered in Barga, Italy.
-
What is the size of Kedrion Biopharma?
Kedrion Biopharma has 5,200 total employees.
-
What industry is Kedrion Biopharma in?
Kedrion Biopharma’s primary industry is Biotechnology.
-
Is Kedrion Biopharma a private or public company?
Kedrion Biopharma is a Private company.
-
What is Kedrion Biopharma’s current revenue?
The current revenue for Kedrion Biopharma is .
-
How much funding has Kedrion Biopharma raised over time?
Kedrion Biopharma has raised $1.78B.
-
Who are Kedrion Biopharma’s investors?
Abu Dhabi Investment Authority, Ampersand (Massachusetts), FSI (Italy), Permira, and CDP Equity are 5 of 7 investors who have invested in Kedrion Biopharma.
-
Who are Kedrion Biopharma’s competitors?
KEDPlasma, CSL Behring, Assertio Holdings, and Regenxbio are competitors of Kedrion Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
